You are here

  • Home
  • Archive
  • Volume 81, Issue 1
  • Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease

Citation Tools

Article menu

Download PDFPDF

Correspondence
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Campochiaro C, Cavalli G, Farina N, et al
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Annals of the Rheumatic Diseases 2022;81:e11.